L. Schnipper

发表

The natural history of recurrent facial-oral infection with herpes simplex virus.

C. Crumpacker, K. Arndt, C. Bader, 1978, The Journal of infectious diseases.

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

C. Crumpacker, M. Levin, J. Zaia, 1979, Antimicrobial Agents and Chemotherapy.

SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases.

S. Weremowicz, C. Morton, C. Adra, 2000, Genomics.

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Adam P Dicker, Thomas J. Smith, Gary H Lyman, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

Thomas J. Smith, J. Vose, R. Schilsky, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow autotransplantation for solid tumors--prospects.

B. Teicher, L. Schnipper, K. Antman, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attitudes and Practices of U.S. Oncologists regarding Euthanasia and Physician-Assisted Suicide

E. Emanuel, E. Bruera, D. Fairclough, 2000, Annals of Internal Medicine.

The crisis in clinical cancer research. Third-party insurance and investigational therapy.

E. Frei, L. Schnipper, K. Antman, 1988, The New England journal of medicine.

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

B. Teicher, J. Eder, A. Elias, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

M. Socinski, S. Cannistra, A. Elias, 1988, The Lancet.

Effects of alpha and beta interferons on cultured human keratinocytes.

B. Gilchrest, M. Yaar, L. Schnipper, 1985, The Journal of investigative dermatology.

Reply to L.k. Griffeth et al and J.E. Battley et al.

R. Schilsky, G. Lyman, D. Blayney, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The costs of conducting clinical research.

E. Emanuel, A. Lichter, J. Levinson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.

B. Teicher, J. Eder, L. Schnipper, 1987, The Journal of clinical investigation.

Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health.

G. Abel, L. Schnipper, 2016, JAMA oncology.

Facing the Global Challenges of Access to Cancer Medication

D. Kerr, L. Schnipper, A. Eniu, 2018, Journal of global oncology.

Converging on the Value of Value Frameworks.

R. Schilsky, L. Schnipper, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DNA Topoisomerase II α Expression Is Associated with Alkylating Agent Resistance

B. Teicher, S. Ng, N. Rizvi, 1995 .

Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital

Hang Lee, P. Thistle, L. Schnipper, 2020, JCO global oncology.

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

B. Teicher, A. Elias, L. Schnipper, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

The rising cost of cancer care: physicians take charge.

L. Schnipper, 2012, Journal of oncology practice.

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.

V. Devita, J. Arseneau, R. Young, 1972, The New England journal of medicine.

American Society of Clinical Oncology’s Global Oncology Leadership Task Force: Findings and Actions

J. Vose, C. Adebamowo, G. Hortobagyi, 2017, Journal of global oncology.

Winning the war on cancer.

R. Mayer, L. Schnipper, 1997, The New England journal of medicine.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Shaun Parsons, E. Guinan, P. Mauch, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cisplatin, continuous‐infusion 5‐fluorouracil, and intermediate‐dose methotrexate in the treatment of unresectable non‐small cell carcinoma of the lung

L. Shulman, S. Come, L. Schnipper, 1991, Cancer.

The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.

A. Elias, L. Schnipper, K. Antman, 1993, Journal of hematotherapy.

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.

C. Begg, T. Shea, J. Eder, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.

D. Rosenthal, G. Bubley, S. Come, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo.

B. Ransil, M. Stemerman, L. Schnipper, 1979, Science.

Providing high-quality and affordable intensive care to patients with cancer: The forgotten brick in the steep wall of costs throughout the cancer care continuum. Reply to M. Soares et al.

P. Ganz, L. Schnipper, Y. T. Shih, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients

T. Shea, J. Eder, A. Elias, 2004, Cancer Chemotherapy and Pharmacology.

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

T. Shea, S. Come, J. Eder, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

C. Crumpacker, G. Bubley, L. Schnipper, 1989, Antimicrobial Agents and Chemotherapy.

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.

P. Richardson, B. Teicher, L. Schnipper, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Repair of DMA following Incorporation of 1-ÃŸ-o-Arabinof uranosy Icytosine into Herpes Simplex Virus Type I1

C. Crumpacker, G. Bubley, L. Schnipper, 2006 .

Repair of DNA following incorporation of 1-beta-D-arabinofuranosylcytosine into herpes simplex virus type 1.

C. Crumpacker, G. Bubley, L. Schnipper, 1984, Cancer research.

Viral infections and cancer.

G. Bubley, L. Schnipper, 1990, Comprehensive therapy.

Enhancement of superoxide anion release by granulocytes harvested from patients receiving granulocyte‐macrophage colony‐stimulating factor

M. Socinski, J. Griffin, A. Elias, 1989, British journal of haematology.

Hans Christian Andersen and the Value of New Cancer Treatments.

R. Schilsky, L. Schnipper, 2018, Journal of the National Cancer Institute.

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols

A. Elias, L. Schnipper, K. Antman, 1991, Breast Cancer Research and Treatment.

Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.

P. Richardson, A. Elias, L. Schnipper, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.

A. Elias, R. Gonin, L. Schnipper, 1995, Bone marrow transplantation.

Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.

B. Teicher, J. Eder, E. Frei, 1989, Cancer research.

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

J. Eder, A. Elias, L. Schnipper, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Payment for cancer care: time for a new prescription.

N. Meropol, L. Schnipper, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Value and Cancer Care: Toward an Equitable Future

N. Meropol, D. Brock, L. Schnipper, 2010, Clinical Cancer Research.

Phase I trial of an interleukin‐2 fusion toxin (DAB486IL‐2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy

T. Woodworth, M. Kadin, L. Schnipper, 1994, Cancer.

Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.

C. Crumpacker, L. Schnipper, A. Field, 1984, Proceedings of the National Academy of Sciences of the United States of America.

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.

A. Elias, L. Schnipper, K. Antman, 1993, Chest.

Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors

G. Demetri, P. Richardson, A. Elias, 1998, Cancer.

DNA topoisomerase II alpha expression is associated with alkylating agent resistance.

B. Teicher, S. Ng, N. Rizvi, 1995, Cancer research.

New Frameworks to Assess Value of Cancer Care: Strengths and Limitations

L. Schnipper, A. Bastian, 2016, The oncologist.

ASCO core values.

I. Tannock, E. Emanuel, S. Joffe, 2006, Journal of Clinical Oncology.

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.

C. Crumpacker, M. Levin, L. Schnipper, 1982, The New England journal of medicine.

Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression

L. Kalish, G. Demetri, T. Lynch, 1994, British journal of haematology.

Effects of Bloom's syndrome fibroblasts on genetic recombination and mutagenesis of herpes simplex virus type 1

G. Bubley, L. Schnipper, 1987, Somatic cell and molecular genetics.

Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support.

D. Schoenfeld, T. Shea, J. Eder, 1988, Archives of dermatology.

Content and expression of integrated viral DNA in hamster cells transformed by nondefective adenovirus type 2- simian virus 40 hybrid viruses

A. Levine, L. Schnipper, A. Lewis, 1976, Journal of virology.

Central IRB Review Is an Essential Requirement for Cancer Clinical Trials

L. Schnipper, 2017 .

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

B. Teicher, T. Shea, J. Eder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line.

S. Ng, J. Eder, L. Schnipper, 1993, The Journal of biological chemistry.

Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo)

L. Schnipper, R. Drews, V. Chan, 1992, Molecular and cellular biology.

Revisions of and clarifications to the ASCO conflict of interest policy.

J. Armitage, E. Emanuel, J. Glick, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey.

E. Emanuel, D. Fairclough, K. Foley, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

N. Girard, J. V. Von Roenn, B. Coiffier, 2016, ESMO Open.

Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.

C. Crumpacker, M. Klauber, S. Spruance, 1979, The New England journal of medicine.

Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.

C. Crumpacker, L. Schnipper, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Inactivation of Herpes Simplex Virus with Methylene Blue, Light and Electricity

C. Crumpacker, A. Lewin, L. Schnipper, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Mechanisms of photodynamic inactivation of herpes simplex viruses: comparison between methylene blue, light plus electricity, and hematoporhyrin plus light.

C. Crumpacker, A. Lewin, L. Schnipper, 1980, The Journal of clinical investigation.

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

M. Socinski, S. Cannistra, J. Griffin, 1988, The New England journal of medicine.

Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol.

C. Crumpacker, K. Arndt, J. Modlin, 1982, The Journal of infectious diseases.

Clinical implications of tumor-cell heterogeneity.

L. Schnipper, L Schnipper, 1986, The New England journal of medicine.

Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and mutagenesis of herpes simplex virus type 1

C. Crumpacker, G. Bubley, L. Schnipper, 1986, Antimicrobial Agents and Chemotherapy.

Incorporation of 1-3-D-Arabinofuranosylcytosine into DNA and Mutagenesis of Herpes Simplex Virus Type 1

C. Crumpacker, G. Bubley, L. Schnipper, 2022 .

Incorporation of 1-/ 3-D-Arabinofuranosylcytosine into DMA from Herpes Simplex Virus Resistant to 9-0D-Arabinofuranosyladenine 1

C. Crumpacker, D. Kufe, L. Schnipper, 2006 .

Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.

C. Crumpacker, L. Schnipper, P. Kowalsky, 1982, The Journal of infectious diseases.

Genetic mechanisms of resistance to acyclovir in herpes simplex virus.

C. Crumpacker, L. Schnipper, P. Chartrand, 1982, The American journal of medicine.

Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: mechanisms of uptake and toxicity.

C. Crumpacker, L. Schnipper, R. Davidson, 1981, Virology.

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir

C. Crumpacker, K. Arndt, S. Spruance, 1984, Antimicrobial Agents and Chemotherapy.

Studies of Nondefective Adenovirus 2-Simian Virus 40 Hybrid Viruses. VI. Characterization of the DNA from Five Nondefective Hybrid Viruses

C. Crumpacker, A. Levine, L. Schnipper, 1973, Journal of virology.

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.

J. Eder, A. Elias, M. Seiden, 1992, Bone marrow transplantation.

Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.

C. Crumpacker, D. Kufe, L. Schnipper, 1984, Cancer research.

Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.

M. van de Rijn, J. Fletcher, G. Demetri, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GM‐CSF mobilized peripheral blood stem cell autografts: The DFCI/BIH experience

A. Elias, L. Schnipper, K. Antman, 1992 .

Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo.

M. Socinski, S. Cannistra, J. Griffin, 1988, Blood.

DRAFT FOR PUBLIC COMMENT Defining Clinically Meaningful Outcomes: ASCO Recommendations to Raise the Bar for Clinical Trials

L. Ellis, C. Sima, D. Sargent, 2013 .

Gene activation by induced DNA rearrangements.

P. Sharp, J. Sedivy, P. Jat, 1989, Cancer research.

Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions.

L. Schnipper, C. Moran, M. Kolker, 1998, Mutation research.

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

L. Ellis, C. Sima, D. Sargent, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delivering high-quality and affordable care throughout the cancer care continuum.

A. Abernethy, J. Goodwin, D. Aberle, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

Thomas J. Smith, Thomas J Smith, P. Ganz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Studies of hamster cells transformed by adenovirus 2 and the nondefective Ad2-SV40 hybrids.

A. Levine, L. Schnipper, A. Lewis, 1975, Cold Spring Harbor symposia on quantitative biology.

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.

D. Fairclough, A. Elias, L. Schnipper, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: updated results.

D. Lake, C. Hudis, L. Norton, 2009 .

All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care.

F. Cavalli, D. George, S. Gillessen, 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

A model state act to authorize and regulate physician-assisted suicide.

D. Brock, L. Schnipper, C. Baron, 1996, Harvard journal on legislation.

Induced hemorrhagic hypotension. Its effect on plasma 5-hydroxytryptamine and plasma 5-hydroxyindole acetic acid levels.

L. Schnipper, J. Stuckey, V. Schenker, 1969, Archives of surgery.

Plasma serotonin levels during total cardiopulmonary bypass.

L. Schnipper, J. Stuckey, M. A. Demos, 1970, The Journal of thoracic and cardiovascular surgery.

Plasma serotonin levels and arfonad-induced hypotension.

L. Schnipper, J. Stuckey, M. A. Demos, 1970, The Journal of surgical research.

American Society of Clinical Oncology 2013 top five list in oncology.

R. Schilsky, G. Lyman, D. Blayney, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American society of clinical oncology statement: toward individualized care for patients with advanced cancer.

Thomas J. Smith, J. V. Von Roenn, J. Peppercorn, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology 2013 Top Five List in

R. Schilsky, G. Lyman, D. Blayney, 2013 .

Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene.

S. Ng, Y. Liu, L. Schnipper, 1997, Gene.

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

Donald W Kufe, Jeffrey W. Clark, J. Folkman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Studies ofNondefective Adenovirus 2-Simian Virus 40Hybrid Viruses. VI.Characterization oftheDNA fromFiveNondefective Hybrid Viruses

L. Schnipper, A. Lewis, A. S. Levine, 1973 .

Trials of 9‐Amino‐20(S)‐Camptothecin in Boston

T. Lynch, L. Shulman, D. Kufe, 1996, Annals of the New York Academy of Sciences.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Thomas J. Smith, P. Ubel, D. Schrag, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase IIα Gene (*)

S. Ng, L. Schnipper, J. Paul Eder, 1995, The Journal of Biological Chemistry.

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study

A. Elias, L. Schnipper, K. Antman, 2005, Journal of Cancer Research and Clinical Oncology.

A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.

B. Teicher, J. Eder, L. Schnipper, 1991, Cancer research.

A magic bullet for cancer--how near and how far?

T. Strom, L. Schnipper, 2001, The New England journal of medicine.

Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.

M. Somerfield, M. Piccart, R. Schilsky, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Funding for clinical (patient-oriented) oncology research: current status and recommendations for improvement. American Society of Clinical Oncology.

P. Scardino, B. Weber, K. Offit, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.

C. Shapiro, P. Richardson, A. Elias, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.

V. Sukhatme, J. Merchan, L. Schnipper, 2003, Journal of the National Cancer Institute.

Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection—case report and review of the literature

B. Halmos, L. Schnipper, E. Ballesteros, 2004, Annals of Hematology.

Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology.

P. Scardino, B. Weber, K. Offit, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus.

C. Crumpacker, B. Gilchrest, L. Schnipper, 1984, The Journal of investigative dermatology.

High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.

A. Elias, L. Schnipper, K. Antman, 1994, Seminars in Oncology.

Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene.

S. Ng, J. Eder, L. Schnipper, 1995, The Journal of biological chemistry.

Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells.

B. Teicher, J. Eder, L. Schnipper, 1993, The Journal of biological chemistry.

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

R. Miksad, L. Schnipper, M. Goldstein, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on DNA repair and mutagenesis of herpes simplex virus type 1.

C. Crumpacker, E. De Clercq, G. Bubley, 1987, Virology.

POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa.

J. Efstathiou, B. Chabner, S. Dryden-Peterson, 2019, The oncologist.

A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors

R. Hellman, T. Tensfeldt, S. Silberman, 2000 .

Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?

M. Somerfield, E. Basch, G. Lyman, 2011, Journal of oncology practice.

Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.

R. Bast, J. Eder, L. Schnipper, 1986, Cancer research.

Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline

B. Teicher, J. Eder, L. Schnipper, 2008, Cancer Chemotherapy and Pharmacology.

Translating Clinical Trials into Meaningful Outcomes

P. LoRusso, Walter Wolf, S. Boerner, 2010, Clinical Cancer Research.

Pharmacokinetics and immediate effects of high-dose carmustine in man.

J. Eder, L. Schnipper, K. Antman, 1986, Cancer treatment reports.

Induction of Cellular DNA Synthesis by the Nondefective Adenovirus 2-Simian Virus 40 Hybrid Viruses

A. Levine, L. Schnipper, A. Lewis, 1973, Journal of Virology.

Cisplatin, continuous‐infusion 5‐fluorouracil, and intermediate‐dose methotrexate in the treatment of unresectable non‐small cell carcinoma of the lung

L. Shulman, S. Come, L. Schnipper, 1991, Cancer.

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

L. Ellis, C. Sima, D. Sargent, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.

C. Crumpacker, E. De Clercq, G. Bubley, 1983, Virology.

Cancer survivorship issues for minority and underserved populations.

Frederick P. Li, T. Gilligan, L. Schnipper, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Enhanced survival of ultraviolet-irradiated herpes simplex virus in cells exposed to antiviral agents.

C. Crumpacker, A. Lewin, L. Schnipper, 1983, Mutation research.

ASCO Task Force on the Cost of Cancer Care.

L. Schnipper, 2009, Journal of oncology practice.

ASCO Addresses the Rising Cost of Cancer Care.

N. Meropol, L. Schnipper, 2009, Journal of oncology practice.

Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?

M. Somerfield, E. Basch, G. Lyman, 2011, Journal of oncology practice.

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016

N. Girard, J. V. Von Roenn, B. Coiffier, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.